» Articles » PMID: 29181680

The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2017 Nov 29
PMID 29181680
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The impact of primary tumor location on overall survival (OS), recurrence-free survival (RFS), and long-term outcomes has not been well established in patients undergoing potentially curative resection of colorectal liver metastases (CRLM).

Methods: A single-institution database was queried for initial resections for CRLM 1992-2004. Primary tumor location determined by chart review (right = cecum to transverse; left = splenic flexure to sigmoid). Rectal cancer (distal 16 cm), multiple primaries, and unknown location were excluded. Kaplan-Meier and Cox regression methods were used. Cure was defined as actual 10-year survival with either no recurrence or resected recurrence with at least 3 years of disease-free follow-up.

Results: A total of 907 patients were included with a median follow-up of 11 years; 578 patients (64%) had left-sided and 329 (36%) right-sided primaries. Median OS for patients with a left-sided primary was 5.2 years (95% confidence interval [CI] 4.6-6.0) versus 3.6 years (95% CI 3.2-4.2) for right-sided (p = 0.004). On multivariable analysis, the hazard ratio for right-sided tumors was 1.22 (95% CI 1.02-1.45, p = 0.028) after adjusting for common clinicopathologic factors. Median RFS was marginally different stratified by primary location (1.3 vs. 1.7 years; p = 0.065). On multivariable analysis, location of primary was not significantly associated with RFS (p = 0.105). Observed cure rates were 22% for left-sided and 20% for right-sided tumors.

Conclusions: Among patients undergoing resection of CRLM, left-sided primary tumors were associated with improved median OS. However, long-term survival and recurrence-free survival were not significantly different stratified by primary location. Patients with left-sided primary tumors displayed a prolonged clinical course suggestive of more indolent biology.

Citing Articles

Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review).

Jin Z, Li Y, Yi H, Wang M, Wang C, Du S Int J Oncol. 2025; 66(3).

PMID: 39950314 PMC: 11844340. DOI: 10.3892/ijo.2025.5728.


Sustained Endocytosis Inhibition via Locally-Injected Drug-Eluting Hydrogel Improves ADCC-Mediated Antibody Therapy in Colorectal Cancer.

Wu C, Liu X, Liu R, Song S, Zheng Z, Zeng Y Adv Sci (Weinh). 2024; 12(2):e2407239.

PMID: 39560161 PMC: 11727399. DOI: 10.1002/advs.202407239.


Somatic Mutations in Surgically Treated Colorectal Liver Metastases: An Overview.

Wang J, Botvinov J, Bhatt A, Beyer K, Kreis M, Adam M Cells. 2024; 13(8.

PMID: 38667294 PMC: 11049420. DOI: 10.3390/cells13080679.


Survival trends for left and right sided colon cancer using population-based SEER database: A forty-five-year analysis from 1975 to 2019.

Ulanja M, Asafo-Agyei K, Neelam V, Beutler B, Antwi-Amoabeng D, Governor S Cancer Med. 2024; 13(8):e7145.

PMID: 38651190 PMC: 11036079. DOI: 10.1002/cam4.7145.


Simultaneous Resection for Colorectal and Liver Metastases, new equipment and personalized medicine.

Zarogoulidis P, Ioannidis A, Vagionas A, Perdikouri E, Christakidis V, Anemoulis M J Cancer. 2024; 15(3):610-614.

PMID: 38213718 PMC: 10777028. DOI: 10.7150/jca.90519.


References
1.
Holch J, Ricard I, Stintzing S, Modest D, Heinemann V . The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials. Eur J Cancer. 2016; 70:87-98. DOI: 10.1016/j.ejca.2016.10.007. View

2.
Pulitano C, Castillo F, Aldrighetti L, Bodingbauer M, Parks R, Ferla G . What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford). 2010; 12(4):244-9. PMC: 2873647. DOI: 10.1111/j.1477-2574.2010.00155.x. View

3.
Tomlinson J, Jarnagin W, DeMatteo R, Fong Y, Kornprat P, Gonen M . Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007; 25(29):4575-80. DOI: 10.1200/JCO.2007.11.0833. View

4.
Allen P, Nissan A, Picon A, Kemeny N, Dudrick P, Ben-Porat L . Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg. 2005; 201(1):57-65. DOI: 10.1016/j.jamcollsurg.2005.03.019. View

5.
Vigano L, Ferrero A, Lo Tesoriere R, Capussotti L . Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol. 2008; 15(9):2458-64. DOI: 10.1245/s10434-008-9935-9. View